only in the presence of menadione, the organism presumably being unable to synthesize the naphthaquinone nucleus. The starfish Asterias rubens and C. maenas incorporated the label into a compound which was identified chromatographically as 2,3-epoxymenaquinone-4. The significance of menaquinone-4 and its epoxy derivative in these animals is discussed.
It has been recognized for many years that vitamin K is required by higher animals for the formation of four blood-clotting proteins, prothrombin and factors VII, IX and X (Naeye, 1956) . Until recently the precise area of function of the vitamin was not understood. In the first place it was thought to be a cofactor for the blood-clotting proteins, then participation in oxidative phosphorylation appeared likely and later it seemed that it played a part in mRNA formation (see Pennock, 1966) . It is now clear, however, that vitamin K is involved in the carboxylation of glutamate residues in precursor proteins, e.g. preprothrombin, to yield the functional bloodclotting factors (Esmon et al., 1975; Fernlund & Stenflo, 1975) . The blood-clotting factors contain several y-carboxyglutamate residues at the N-terminal part of the protein and these residues are involved in Ca2+ binding. In the absence of vitamin K, carboxylation does not occur and prothrombin and the other factors are not formed.
As yet it is not clear how the vitamin fulfils its role in y-carboxylation, but it appears to function during the carboxylation reaction. When microsomal fractions from vitamin K-deficient rats (which have present the precursor protein awaiting carboxylation) are incubated with phylloquinone (vitamin K1), NaH14CO3 and a little cytoplasm, the label appears in the prothrombin in 15min, and it can be shown that the radioactivity is located in the carboxyl groups of y-carboxyglutamate residues (Esmon et al., 1975) .
Whether vitamin K plays a coenzymic role remains to be seen.
Little or nothing is known of metabolites of vitaVol. 162 min K in animals except phylloquinone 2,3-oxide. This compound was isolated as a metabolite ofphylloquinone in rats and was then shown to have vitamin K activity in the vitamin K-deficient rat . The two compounds-appeared to be interconvertible, but the anticoagulant Warfarin blocked the formation of phylloquinone from its oxide . The metabolic significance of the oxide at present remains undecided.
The requirement for vitamin K by higher animals can be satisfied by menadione, and it is reasonable to suppose that it is functional after addition of a polyprenyl side chain to form a menaquinone. Chickens and rats have been shown to form menaquinone-4 after administration of menadione, and in particular themicrosomalfractionofvitaminK-deficientchicken liver was able to condense menadione with geranylgeranyl pyrophosphate to yield menaquinone-4 (Martius & Esser, 1958; Taggart &Matschiner, 1969; Dialameh et al., 1970) .
The problem arises as to how widespread the role ofvitamin K in carboxylation is in the animal kindom. Is carboxylation of glutamate residues to form a Ca2+-binding protein specific only for blood-clotting proteins, or are other such proteins vitamin Kdependent? The purpose of this paper is to examine the status of vitamin K in organisms that do not have the four blood-clotting proteins mentioned above and in fact do not possess a similar type of coagulation system. Such animals are to be found in invertebrate phyla. Martius et al. (1965) 2,3-Epoxymenaquinones-3 and -4 were formed by treatment of the relevant menaquinone with H202 in aqueous ethanol containing Na2CO3 (Tishler et al., 1940) . The epoxides were purified by preparative t.l.c., utilizing adsorption and reversed-phase systems (see Table 1 ).
Methods
Incubation Injection was accomplished by a variety of methods; through the mouth for the sea-urchins (Psammechinus miliaris and Echinus esculentis) and sea-anemone (Actinia equina), through the leg joint for the crab (Carcinus maenas), into the coelomic cavity for the starfish (Asterias rubens), and into the foot muscle for the whelk (Buccinwn wudatwn). The animals were maintained in small aquaria for 24h before being killed.
Extraction of lipids. After removal of shell (where present) the organism or tissue was homogenized in chloroform/methanol (2:1, v/v), the extract was filtered, methanol was removed by washing with water and finally the chloroform extract was dried over Na2SO4. At this stage carrier amounts of menaquinone-4 (210 umol) were added, because in initial 1977 Table 1 . Thin-aer-chromatographicproperties ofmenaquinones-3 and4 and 2,3-epoxymenaquidone-4 Thin layers of silica gel G were 0.25mm thick for aalytical work and 0.5mm for preparative work (system 1). The diisopropyl ether used in system 2 was passed through 4 column ofacid-washed alumina (Brockmann grade O)just before use to remove the quinol (hydroquinone) normally present to prevent peroxide formation. Thereversed-phase system 3 is described by Walton & Pennock (1972) . RF values are given in the 5.Omin, menaquinone-3, 17.0mi, 2,3-epoxymenaquinone-4, 20.0min, and menaquinone-4, 27.5mi.
Radioactivity. This was detected as described by Walton & Pennock (1972) .
[14C]Menadione (12.5,uCi, 244,g) was injected into two shore crabs (C. maenas) and a simiar amount into six small sea-urchins (Psammechinus niliaris). After a 24h incubation the animals were killed and the lipids extracted and fractionated as described in the Experimental section. The vitamin K fraction was found to be radioactively labelled and in each organism radioactivity co-chromatographed with menaquinone4 in all three t.l.c. systems. Menaquinone-4 contained a total of 4838 d.p.m. in C. nzaenas and 13630 d.p.m. in P. miliaris, and in C. maenas a related compound (which was later shown to be 2,3-epoxymenaquinone-4) contained a total of 2842 d.p.m. No other menaquinone homologue was found to be labelled and in each case only radioactivity was detected, no menaquinone-4 was found chemically.
Identification of2,3-epoxymenaquinone-4
In the experiments with ['4C]menadione described above and in later experiments with [2-14C]mevalonate, radioactivity was detected in a comnpound from C. maenas lipids which was similar to menaquinone-4 in chromatographic properties but distinguishable from it on some systems. The unknown metabolite migrated like menaquinone-4 or -3 on adsorption t.l.c., was identical with menaquinone-3 on reversedphase t.l.c., but ran slower than either menaquinone-3 or -4 on argentation t.l.c. This compound, being labelled with either [14C]nenadione or [2-14C]mevaIonic acid as precursor, was clearly related to men- quinone-4, but also from its chromatographic properties could not be a related homologue, e.g. menaquinone-3 or menaquinone-5.
In the rat, 2,3-epoxyphylloquinone has been found to be a metabolite of exogenous phylloquinone and such an epoxide related to menaquinone-4 might well account for the properties of the unknown metabolite. Accordingly 2,3-epoxymenaquinone-4 was formed by oxidation of menaquinone-4 with H202 and its identity confirmed by mass spectrometry in an A.E.1 M.S.12 mass spectrometer.
The mass spectrum showed a molecular ion at mie 460 as expected and major fragment peaks at (1) mle 391 (M-69), (2) mle 323 (M-137) and (3) mle 255 (M-205), corresponding to the loss of one, two and three isoprene units respectively.
Another peak (mle 213) could be the 2,3-epoxyquinone with a vinyl group at position 2. No major fragment peak was observed to correspond to the pyrylium ion proposed by Di Mari et al. (1966) in the mass spectrum of phylloqulnone. This is to be expected, as the stable pyrylium ion requires the presence of a quinoid nucleus and in the 2,3-epoxymenaquinone-4 this structure has been lost by epoxidation.
The chromatographic properties ofthe epoxymenaquinone-4 are shown in Table 1 with those of menaquinone-4, which illustrates that the former migrates to exactly the same position as the unknown metabolite described above, i.e. migrating with menaquinones-3 and -4 on adsorption t.l.c., with menaquinone-3 on reversed-phase t.l.c. and just behind menaquinone-4 on argentation t.l.c. Carrier 2,3-epoxymenaquinone was added to the radioactive metabolite and radioactivity accompanied the carrier on all three t.l.c. systems and also was inseparable from carrier on high-pressure liquid chromatography. (10, uCi) were injected into each animal or, if more than one animal was used, the dose was equally divided between animals in that group and the incubation carried on for 24h. The animals were killed and treated as above and the results are shown in Table 3 . All animals synthesized menaquinone-4 to some extent. The relatively low incorporation of radioactivity into menaquinone-4 in the whelk (Buccinum undatum) may well reflect the difficulties encountered in injecting both menadione and mevalonate into the extremely hard foot muscle. In the starfish 1977 (Walton & Pennock, 1972) , and yet no menaquinone-3 was detected in the experiments described here. Therefore the formation of menaquinone-4 suggests a quite specific enzymic reaction.
If menaquinone-4 is made as a routine in invertebrates, what is the source of the naphthoquinone nucleus? Without added menadione no menaquinone-4 was synthesized by C. maenas, and as far as is known menadione is not a naturally occurring compound. Billeter & Martius (1960) reported that pigeons and chickens were capable of removing the phytyl side chain of vitamin K1 (phylloquinone) and utilizing the nucleus for menaquinone-4 synthesis, and this seems to be a possibility, particularly in herbivorous animals, who are likely to obtain plenty of phylloquinone in the diet. Alternatively there may be a trace of a naphthalenic compound in the diet which can be converted by the invertebrate into naphthoquinone or a similar nuclear precursor of menaquinone.
What is the most likely function, if any, of menaquinone-4 in these invertebrates? In some bacteria, ubiquinone is not present in the electron-transport chain and its place is essentially taken by a menaquinone (see Pennock, 1966) . It is possible that in invertebrates menaquinone-4 functions in the mitochondrial electron-transport chain in place of ubiquinone. However, although little is known about electron transport in invertebrates, ubiquinone has been found to be present and to function in mitochondrial electron transport in C. maenas (Burrin & Beechey, 1966) ; all the animals used in the present study have been shown to contain and synthesize ubiquinone, and therefore a role for menaquinone-4 in electron transport seems unlikely.
In mammals vitamin K is needed for y-carboxylation of glutamate residues in the formation of four blood-clotting zymogens, but although invertebrate blood does 'clot', the process is different from the mammalian system, and the blood-clotting zymogens are not involved (Fuller & Doolittle, 1972) . The four blood-clotting factors are zymogens of proteolytic enzymes, and presumably during evolution of the mammalian clotting system, zymogens passing in the bloodstream from the liver, where they are made to the gut, where they would function in digestion, have been adapted to a blood-clotting role. Therefore in invertebrates these or similar zymogens may contain y-carboxyglutamate residues and may function in digestion, and of course would need menaquinone for their formation.
Alternatively the role of vitamin K in y-carboxylation of glutamate residues in proteins may not be confined to the four blood-clotting factors. y-Carboxyglutamates may occur in other Ca2+-binding proteins, all requiring vitamin K for their synthesis, and indeed there is evidence of at least one other protein of unknown function purified from bovine plasma (Stenflo, 1976) .
The finding that as well as menaquinone-4 a derivative, 2,3-epoxymenaquinone-4, is also formed in some of the animals is of great interest. As described in the introduction, 2,3-epoxyphylloquinone is formed from phylloquinone in rats, especially in the presence of anticoagulants . The hypothesis of is that warfarin inhibits the conversion of the epoxy derivative into phylloquinone and so a phylloquinone (or vitamin K) deficiency occurs and 2,3-epoxtyphylloquinone might in fact act as a competitive inhibitor. The formation of 2,3-epoxymenaquinone-4 in some ofthese marine invertebrates in proportions as high as those of menaquinone-4 suggests a possible role for the oxide. The formation of menaquinone-4 in rats and invertebrates and the occurrence of 2,3-epoxyphylloquinone or 2,3-epoxymenaquinone in rats and invertebrates might be coincidence, but it is tempting to suggest that menaquinone-4 plays a role in y-carboxylation of glutamate residues in rats and invertebrates and that 2,3-epoxyphylloquinone or 2,3-epoxymenaquinone-4 is involved in this reaction.
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